- Home
- TWN vs EBS Comparison
TWN vs EBS Comparison
Compare TWN & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWN
- EBS
- Stock Information
- Founded
- TWN 1986
- EBS 1998
- Country
- TWN Hong Kong
- EBS United States
- Employees
- TWN N/A
- EBS N/A
- Industry
- TWN Trusts Except Educational Religious and Charitable
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- TWN Finance
- EBS Health Care
- Exchange
- TWN Nasdaq
- EBS Nasdaq
- Market Cap
- TWN 305.8M
- EBS 359.3M
- IPO Year
- TWN N/A
- EBS 2006
- Fundamental
- Price
- TWN $54.71
- EBS $7.93
- Analyst Decision
- TWN
- EBS Strong Buy
- Analyst Count
- TWN 0
- EBS 3
- Target Price
- TWN N/A
- EBS $14.33
- AVG Volume (30 Days)
- TWN 20.1K
- EBS 944.7K
- Earning Date
- TWN 01-01-0001
- EBS 11-05-2025
- Dividend Yield
- TWN 1.10%
- EBS N/A
- EPS Growth
- TWN N/A
- EBS N/A
- EPS
- TWN N/A
- EBS 2.53
- Revenue
- TWN N/A
- EBS $851,600,000.00
- Revenue This Year
- TWN N/A
- EBS N/A
- Revenue Next Year
- TWN N/A
- EBS $19.24
- P/E Ratio
- TWN N/A
- EBS $3.13
- Revenue Growth
- TWN N/A
- EBS N/A
- 52 Week Low
- TWN $25.22
- EBS $4.02
- 52 Week High
- TWN $41.51
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- TWN 75.80
- EBS 48.37
- Support Level
- TWN $53.00
- EBS $7.75
- Resistance Level
- TWN $54.50
- EBS $8.13
- Average True Range (ATR)
- TWN 0.85
- EBS 0.37
- MACD
- TWN 0.14
- EBS -0.08
- Stochastic Oscillator
- TWN 95.45
- EBS 41.03
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.